Is the Fixed Periodic Treatment Effective for the Tumor System without Complete Information?

References

• Loeb LA, Kohrn BF, Loubet-Senear KJ, et al. Extensive subclonal mutational diversity in human colorectal cancer and its significance. Proc Natl Acad Sci U S A. 2019;116:26863–26872. doi:10.1073/pnas.1910301116
   PubMed Web of Science ®Google Scholar
• Campbell PJ, Pleasance ED, Stephens PJ, et al. Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proc Natl Acad Sci U S A. 2008;105(35):13081–13086. doi:10.1073/pnas.080152310518723673
   PubMed Web of Science ®Google Scholar
• Diaz LA, Williams RT, Wu J, et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature. 2012;486(7404):537–540. doi:10.1038/nature1121922722843
   PubMed Web of Science ®Google Scholar
• Gentles AJ, Hui AB, Feng W, et al. A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk. Genome Biol. 2020;21(1):107. doi:10.1186/s13059-020-02019-x32381040
   PubMed Web of Science ®Google Scholar
• Lee JK, Choi YL, Kwon M, Park PJ. Mechanisms and consequences of cancer genome instability: lessons from genome sequencing studies. Annu Rev Pathol. 2016;11:283–312. doi:10.1146/annurev-pathol-012615-04444626907526
   PubMed Web of Science ®Google Scholar
• Coffey DS. Self-organization, complexity and chaos: the new biology for medicine. Nat Med. 1998;4(8):882–885. doi:10.1038/nM0898-8829701230
   PubMed Web of Science ®Google Scholar
• Jiao Y, Berman H, Kiehl TR, Torquato S. Spatial organization and correlations of cell nuclei in brain tumors. PLoS One. 2011;6(11):e27323. doi:10.1371/journal.pone.002732322110626
   PubMed Web of Science ®Google Scholar
• Deisboeck TS, Berens ME, Kansal AR, Torquato S, Stemmer-Rachamimov AO, Chiocca EA. Pattern of self-organization in tumour systems: complex growth dynamics in a novel brain tumour spheroid model. Cell Prolif. 2001;34(2):115–134. doi:10.1046/j.1365-2184.2001.00202.x11348426
   PubMed Web of Science ®Google Scholar
• Jamous S, Comba A, Lowenstein PR, Motsch S. Self-organization in brain tumors: how cell morphology and cell density influence glioma pattern formation. PLoS Comput Biol. 2020;16(5):e1007611. doi:10.1371/journal.pcbi.100761132379821
   PubMed Web of Science ®Google Scholar
• Fitzgerald DM, Rosenberg SM. Driving cancer evolution. eLife. 2017;6. doi:10.7554/eLife.25431.
   Web of Science ®Google Scholar
• West J, You L, Zhang J, et al. Towards multidrug adaptive therapy. Cancer Res. 2020;80(7):1578–1589. doi:10.1158/0008-5472.CAN-19-266931948939
   PubMed Web of Science ®Google Scholar
• Gatenby RA, Silva AS, Gillies RJ, Frieden BR. Adaptive therapy. Cancer Res. 2009;69(11):4894–4903. doi:10.1158/0008-5472.CAN-08-365819487300
   PubMed Web of Science ®Google Scholar
• Enriquez-Navas PM, Kam Y, Das T, et al. Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer. Sci Transl Med. 2016;8(327):327ra24. doi:10.1126/scitranslmed.aad7842
   PubMed Web of Science ®Google Scholar
• Zhang J, Cunningham JJ, Brown JS, Gatenby RA. Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer. Nat Commun. 2017;8(1):1816. doi:10.1038/s41467-017-01968-529180633
   PubMed Web of Science ®Google Scholar
• Enriquez-Navas PM, Wojtkowiak JW, Gatenby RA. Application of evolutionary principles to cancer therapy. Cancer Res. 2015;75(22):4675–4680. doi:10.1158/0008-5472.CAN-15-133726527288
   PubMed Web of Science ®Google Scholar
• Gatenby RA. A change of strategy in the war on cancer. Nature. 2009;459(7246):508–509. doi:10.1038/459508a19478766
   PubMed Web of Science ®Google Scholar
• Monro HC, Gaffney EA. Modelling chemotherapy resistance in palliation and failed cure. J Theor Biol. 2009;257(2):292–302. doi:10.1016/j.jtbi.2008.12.00619135065
   PubMed Web of Science ®Google Scholar
• Yesilkanal AE, Johnson GL, Ramos AF, Rosner MR. New strategies for targeting kinase networks in cancer. J Biol Chem. 2021;297:101128. doi:10.1016/j.jbc.2021.10112834461089
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi:10.1093/nar/gkv00725605792
   PubMed Web of Science ®Google Scholar
• Yang W, Soares J, Greninger P, et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2013;41(Databaseissue):D955–61. doi:10.1093/nar/gks111123180760
   PubMed Web of Science ®Google Scholar
• Wu D, Zhu ZQ, Tang HX, et al. Efficacy-shaping nanomedicine by loading calcium peroxide into tumor microenvironment-responsive nanoparticles for the antitumor therapy of prostate cancer. Theranostics. 2020;10(21):9808–9829. doi:10.7150/thno.4363132863961
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Chakraborty P, Daenthanasanmak A, et al. Targeting PIM kinase with PD1 inhibition improves immunotherapeutic antitumor T-cell response. Clin Cancer Res. 2019;25(3):1036–1049. doi:10.1158/1078-0432.CCR-18-070630327305
   PubMed Web of Science ®Google Scholar
• Choi J, Beaino W, Fecek RJ, et al. Combined VLA-4-targeted radionuclide therapy and immunotherapy in a mouse model of melanoma. J Nucl Med. 2018;59(12):1843–1849. doi:10.2967/jnumed.118.20951029959213
   PubMed Web of Science ®Google Scholar
• Sano D, Xie TX, Ow TJ, et al. Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer. Clin Cancer Res. 2011;17(21):6658–6670. doi:10.1158/1078-0432.CCR-11-004621903770
   PubMed Web of Science ®Google Scholar
• Zhou Y, Gu H, Xu Y, et al. Targeted antiangiogenesis gene therapy using targeted cationic microbubbles conjugated with CD105 antibody compared with untargeted cationic and neutral microbubbles. Theranostics. 2015;5(4):399–417. doi:10.7150/thno.1035125699099
   PubMed Web of Science ®Google Scholar
• Pachow D, Andrae N, Kliese N, et al. mTORC1 inhibitors suppress meningioma growth in mouse models. Clin Cancer Res. 2013;19(5):1180–1189. doi:10.1158/1078-0432.CCR-12-190423406776
   PubMed Web of Science ®Google Scholar
• Kuo C, Coquoz O, Troy TL, Xu H, Rice BW. Three-dimensional reconstruction of in vivo bioluminescent sources based on multispectral imaging. J Biomed Opt. 2007;12(2):024007. doi:10.1117/1.271789817477722
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang Y, Liu X, Liu H. Optimizing adaptive therapy based on the reachability to tumor resistant subpopulation. Cancers. 2021;13(21):5262. doi:10.3390/cancers1321526234771426
   PubMed Web of Science ®Google Scholar
• Volterra V. Fluctuations in the abundance of a species considered mathematically. Nature. 1926;118(2972):560.
   Google Scholar
• Lavielle M, Ribba B. Enhanced method for diagnosing pharmacometric models: random sampling from conditional distributions. Pharm Res. 2016;33(12):2979–2988. doi:10.1007/s11095-016-2020-327604892
   PubMed Web of Science ®Google Scholar
• Obenauf AC, Zou Y, Ji AL, et al. Therapy-induced tumour secretomes promote resistance and tumour progression. Nature. 2015;520(7547):368–372. doi:10.1038/nature1433625807485
   PubMed Web of Science ®Google Scholar
• Kuhn E, Lavielle M. Maximum likelihood estimation in nonlinear mixed effects models. Comput Stat Data Anal. 2005;49(4):1020–1038. doi:10.1016/j.csda.2004.07.002
   Web of Science ®Google Scholar
• Pelham CJ, Nagane M, Madan E. Cell competition in tumor evolution and heterogeneity: merging past and present. Semin Cancer Biol. 2020;63:11–18. doi:10.1016/j.semcancer.2019.07.00831323289
   PubMed Web of Science ®Google Scholar
• Parker TM, Gupta K, Palma AM, et al. Cell competition in intratumoral and tumor microenvironment interactions. EMBO J. 2021;40(17):e107271. doi:10.15252/embj.202010727134368984
   PubMed Web of Science ®Google Scholar